Cameroon vs Myanmar: Cause of death, by non-communicable diseases, ages 5-14
Cameroon
25.8%
in 2021
Myanmar
25.0%
in 2021
Cameroon rank
131st
Myanmar rank
133rd
Cause of death, by non-communicable diseases, ages 5-14 over time
- Cameroon
- Myanmar
How they compare
Cameroon currently reports 25.8% against 25.0% in Myanmar, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Myanmar ahead.
Cameroon ranks 131st and Myanmar ranks 133rd of 185 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 20.1% | 7.1% | Myanmar |
| 2010s | 21.3% | 26.4% | 5.1% | Myanmar |
| 2020s | 25.3% | 27.8% | 2.5% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Cameroon or Myanmar?
- Cameroon, at 25.8% against 25.0% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Cameroon and Myanmar?
- 0.8%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Cameroon and Myanmar rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Cameroon ranks 131st and Myanmar ranks 133rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.